| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | MEDP | Common Stock | Sale | $2,013,678 | -11,026 | -0.18% | $182.63 | 6,165,112 | 14 Jul 2021 | Direct | F1, F2 |
| transaction | MEDP | Common Stock | Sale | $2,491,210 | -13,697 | -0.22% | $181.88 | 6,151,415 | 15 Jul 2021 | Direct | F1, F3 |
| Id | Content |
|---|---|
| F1 | The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2021. |
| F2 | The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $181.655 to $184.18. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. |
| F3 | The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $180.38 to $183.34. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. |